MK-886 (sodium salt) |
A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… |
25 mg |
10133-25 |
More Info
|
MK-886 (sodium salt) |
A potent FLAP antagonist that prevents 5-LO activation in vivo; inhibits L… |
5 mg |
10133-5 |
More Info
|
MKT-077 |
A cationic rhodacyanine dye that inhibits the Hsp70 family of chaperones;… |
1 mg |
14395-1 |
More Info
|
MKT-077 |
A cationic rhodacyanine dye that inhibits the Hsp70 family of chaperones;… |
10 mg |
14395-10 |
More Info
|
MKT-077 |
A cationic rhodacyanine dye that inhibits the Hsp70 family of chaperones;… |
25 mg |
14395-25 |
More Info
|
MKT-077 |
A cationic rhodacyanine dye that inhibits the Hsp70 family of chaperones;… |
5 mg |
14395-5 |
More Info
|
MK-4827 (tosylate) |
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 n… |
10 mg |
20842-10 |
More Info
|
MK-4827 (tosylate) |
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 n… |
25 mg |
20842-25 |
More Info
|
MK-4827 (tosylate) |
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 n… |
5 mg |
20842-5 |
More Info
|
MK-4827 (tosylate) |
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 n… |
50 mg |
20842-50 |
More Info
|
ML-030 |
A triazolothiadiazine that inhibits PDE4 (EC50 = 18.7 nM in a cell-based a… |
1 mg |
15169-1 |
More Info
|
ML-030 |
A triazolothiadiazine that inhibits PDE4 (EC50 = 18.7 nM in a cell-based a… |
10 mg |
15169-10 |
More Info
|
ML-030 |
A triazolothiadiazine that inhibits PDE4 (EC50 = 18.7 nM in a cell-based a… |
25 mg |
15169-25 |
More Info
|
ML-030 |
A triazolothiadiazine that inhibits PDE4 (EC50 = 18.7 nM in a cell-based a… |
5 mg |
15169-5 |
More Info
|
ML-031 |
One of the first indentified agonists of S1P2 demonstrating an EC50 value… |
1 mg |
15171-1 |
More Info
|
ML-031 |
One of the first indentified agonists of S1P2 demonstrating an EC50 value… |
10 mg |
15171-10 |
More Info
|
ML-031 |
One of the first indentified agonists of S1P2 demonstrating an EC50 value… |
25 mg |
15171-25 |
More Info
|
ML-031 |
One of the first indentified agonists of S1P2 demonstrating an EC50 value… |
5 mg |
15171-5 |
More Info
|
ML-090 |
The first identified NOX1-specific inhibitor (IC50 = 360 nM in HEK293 cell… |
10 mg |
15172-10 |
More Info
|
ML-090 |
The first identified NOX1-specific inhibitor (IC50 = 360 nM in HEK293 cell… |
25 mg |
15172-25 |
More Info
|
ML-090 |
The first identified NOX1-specific inhibitor (IC50 = 360 nM in HEK293 cell… |
50 mg |
15172-50 |
More Info
|
ML-097 |
A small molecule pan activator of Ras-related GTPases, activating cdc42, R… |
1 mg |
15174-1 |
More Info
|
ML-097 |
A small molecule pan activator of Ras-related GTPases, activating cdc42, R… |
10 mg |
15174-10 |
More Info
|
ML-097 |
A small molecule pan activator of Ras-related GTPases, activating cdc42, R… |
25 mg |
15174-25 |
More Info
|
ML-097 |
A small molecule pan activator of Ras-related GTPases, activating cdc42, R… |
5 mg |
15174-5 |
More Info
|
ML-098 |
An activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) that demonst… |
1 mg |
15175-1 |
More Info
|
ML-098 |
An activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) that demonst… |
10 mg |
15175-10 |
More Info
|
ML-098 |
An activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) that demonst… |
25 mg |
15175-25 |
More Info
|
ML-098 |
An activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) that demonst… |
5 mg |
15175-5 |
More Info
|
ML-099 |
A small molecule pan activator of Ras-related GTPases, activating Rac1, cd… |
1 mg |
15176-1 |
More Info
|
ML-099 |
A small molecule pan activator of Ras-related GTPases, activating Rac1, cd… |
10 mg |
15176-10 |
More Info
|
ML-099 |
A small molecule pan activator of Ras-related GTPases, activating Rac1, cd… |
25 mg |
15176-25 |
More Info
|
ML-099 |
A small molecule pan activator of Ras-related GTPases, activating Rac1, cd… |
5 mg |
15176-5 |
More Info
|
ML-115 |
A cell-permeable STAT3 activator (EC50 = 2 nM) that is more than 28,000-fo… |
1 mg |
15178-1 |
More Info
|
ML-115 |
A cell-permeable STAT3 activator (EC50 = 2 nM) that is more than 28,000-fo… |
5 mg |
15178-5 |
More Info
|
ML-115 |
A cell-permeable STAT3 activator (EC50 = 2 nM) that is more than 28,000-fo… |
500 µg |
15178-500 |
More Info
|
ML-141 |
A noncompetitive, allosteric inhibitor of Cdc42 (EC50 = 2.1 µM) with… |
1 mg |
18496-1 |
More Info
|
ML-141 |
A noncompetitive, allosteric inhibitor of Cdc42 (EC50 = 2.1 µM) with… |
10 mg |
18496-10 |
More Info
|
ML-141 |
A noncompetitive, allosteric inhibitor of Cdc42 (EC50 = 2.1 µM) with… |
5 mg |
18496-5 |
More Info
|
ML-145 |
An antagonist of GPR35; inhibits zaprinast-, cromolyn-, or pamoic acid-ind… |
1 mg |
33534-1 |
More Info
|
ML-145 |
An antagonist of GPR35; inhibits zaprinast-, cromolyn-, or pamoic acid-ind… |
10 mg |
33534-10 |
More Info
|
ML-145 |
An antagonist of GPR35; inhibits zaprinast-, cromolyn-, or pamoic acid-ind… |
5 mg |
33534-5 |
More Info
|
ML-148 |
A selective 15-PGDH inhibitor with an IC50 value of 56 nM |
1 mg |
20475-1 |
More Info
|
ML-148 |
A selective 15-PGDH inhibitor with an IC50 value of 56 nM |
5 mg |
20475-5 |
More Info
|
ML-148 |
A selective 15-PGDH inhibitor with an IC50 value of 56 nM |
500 µg |
20475-500 |
More Info
|
ML-154 |
An NPSR antagonist; selective for NPSR over AVP receptor V1B, as well as a… |
1 mg |
30200-1 |
More Info
|
ML-154 |
An NPSR antagonist; selective for NPSR over AVP receptor V1B, as well as a… |
10 mg |
30200-10 |
More Info
|
ML-154 |
An NPSR antagonist; selective for NPSR over AVP receptor V1B, as well as a… |
5 mg |
30200-5 |
More Info
|
ML-161 |
An allosteric, reversible inhibitor of PAR1 on platelets, preventing surfa… |
1 mg |
15179-1 |
More Info
|
ML-161 |
An allosteric, reversible inhibitor of PAR1 on platelets, preventing surfa… |
10 mg |
15179-10 |
More Info
|